The burden of depression and anxiety in general medicine.
about
Overexpression of acid-sensing ion channel 1a in transgenic mice increases acquired fear-related behaviorUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderPsychophysiological effects of a web-based stress management system: a prospective, randomized controlled intervention study of IT and media workers [ISRCTN54254861].Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesAttenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice.Decreased expression of synapse-related genes and loss of synapses in major depressive disorderFamily doctors' problems and motivating factors in management of depression.Reduction in symptoms for homebound patients receiving home-based primary and palliative careMagnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersAge of onset of social anxiety disorder in depressed outpatientsCost-effectiveness of problem-solving treatment in comparison with usual care for primary care patients with mental health problems: a randomized trial.Patient characteristics that may predict the likelihood of the presence of mental health problems in patients attending the general outpatient clinic of a tertiary hospital in South-South Nigeria.A cross-sectional population-based study on the association of personality traits with anxiety and psychological stress: Joint modeling of mixed outcomes using shared random effects approach.A Web-based screening instrument for depression and anxiety disorders in primary care.Dementia-specific assisted living: clinical factors and psychotropic medication use.What to do if an initial antidepressant fails?Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort studyTreatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial.Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey.Clinical interventions for late-life anxious depression.In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors.Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression.Early Childhood Adversity and its Associations With Anxiety, Depression, and Distress in Women With Breast Cancer.Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.Ablation of Type III Adenylyl Cyclase in Mice Causes Reduced Neuronal Activity, Altered Sleep Pattern, and Depression-like Phenotypes.The development of the visual screening tool for anxiety disorders and depression: Addressing barriers to screening for depression and anxiety disorders in hypertension and/or diabetes.
P2860
Q24633434-E47682D5-BFB9-41A1-AFD8-253A06B72EADQ24802062-447AFE76-7D58-47D2-BC41-A02454915B0AQ24810886-8C257EE7-3EF3-46DE-ABCC-F421EDE2B378Q26861338-66A014FD-936F-4DCF-860A-A2436D4C8C4BQ27320071-044A217F-3014-4027-B404-DCDC2AA50950Q28580177-B1C6E02D-293D-4362-BD58-FE5BDAE6C087Q33262101-5C1DC2BD-6690-45FC-AF91-EA80D05CCE70Q34013561-B4791712-8388-4616-B722-CC80DE5BA75AQ34204211-ACA05361-4CF4-4D35-B496-B141D199AF3FQ34427082-316C64CB-C639-4AE4-A2C0-AC65F8F905D0Q34439498-ECDB1E53-8EC1-42C1-A5EF-0DB5EE288530Q34480716-D4CC3E73-F014-4608-9606-60B121D15E56Q34715969-A5F868F8-C046-42D5-917E-4D6B9544EDBBQ34998078-6FF8B002-D793-417B-B3BF-BE8B24BF49B1Q35065091-E5BDBD88-D794-409F-AF4C-7B276165CA9DQ35120533-276983D8-0D9C-45C5-B925-50A7D3EBCEE8Q36008600-1D2C8A74-538F-4F60-8605-40966E351936Q36208764-A4CF5D6D-2143-482B-98B2-B6B7E6299F2CQ36496179-32FA3F7C-FE30-419F-BE6C-9BFA2F74775AQ37019068-9BB6C0F6-8A81-4147-851B-5810049C7EAFQ37101227-3703C883-3B83-41DE-983B-0F9F1FC1FA9FQ37240212-0A41430C-E01E-4B6E-9014-F341FD2EBF5DQ37255603-EBBABA41-3311-4450-8890-9DE12C26E7D5Q37741989-85333DEF-B103-4C48-A7D9-FA4F6DB18C5CQ47414228-D0D5758A-43BB-4CF4-ABBC-1FCEC31EBE5AQ47558069-36963D7B-113E-469F-83A4-C91571D08C01Q47888461-DC2B4A67-1675-4651-8889-7CB36689395AQ55415652-E71DE565-F537-43F5-A4C0-47661D712711
P2860
The burden of depression and anxiety in general medicine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The burden of depression and anxiety in general medicine.
@ast
The burden of depression and anxiety in general medicine.
@en
The burden of depression and anxiety in general medicine.
@nl
type
label
The burden of depression and anxiety in general medicine.
@ast
The burden of depression and anxiety in general medicine.
@en
The burden of depression and anxiety in general medicine.
@nl
prefLabel
The burden of depression and anxiety in general medicine.
@ast
The burden of depression and anxiety in general medicine.
@en
The burden of depression and anxiety in general medicine.
@nl
P1476
The burden of depression and anxiety in general medicine
@en
P2093
Lecrubier Y
P304
4-9; discussion 10-1
P478
62 Suppl 8
P577
2001-01-01T00:00:00Z